Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease
Calliditas Therapeutics AB
· 2012
ClinicalTrials.gov · Datasets · License: Public Domain · 2012
Open Source ↗
primary iga nephropathy, iga nephropathy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
#995651
Sacituzumab Govitecan Plus EV in Metastatic UC
#995652
Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
#995654
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
#995650
Effects of Multimodal Exercises Integrated With Cognitive-behavioral Therapy in Subjects With Chronic Neck Pain
#995653
Record
· ID 811431
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.